Clearly, anyone creating a new scam (sorry, I mean “high pseudo-impact”) OA journal would want to copy from the best. MedCrave copying from OMICS just proves the legitimacy of OMICS as a leader in its market segment.
I also eagerly await the follow-on surgery imprint “MedCarve” from the same publishers, which I hear will be closely associated with the prestigious “Association of ByoCranks”.
And, since this is the InterWebs: yes, satire.
